Skip to main content

Innovative Oral Treatment Options for Patients


6:30 pm - 8:00 pm

Innovative Oral Treatment Options for Patients: HR+/HER2- mBC or gBRCA-Mutated
Triple-Negative and HR+/HER2- mBC – A virtual Event


Presented by:
Attending Physician, Breast Medicine Service
Medical Director, Bobst International Center
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College


Please RSVP to your Pfizer Representative
Dahlia Mann: (310) 422-7978,

Kindly provide your full name, degree, specialty, address including state, and email address when registering so that you can be confirmed. Please also reference Meeting ID# INT-0061719


Click here for more information.